New drugs needed to tackle superbugs

Source: Agencies | September 17, 2009, Thursday |

Online Edition

EUROPEAN health agencies warn there are not enough new drugs under development to tackle the growing problem of superbugs in Europe.

In a joint report, the European Centre for Disease Control and the European Medicines Agency urge policy-makers to set up global and European strategies to address the problem of multidrug-resistant bacteria.

They say around 25,000 patients die in the European Union each year from antibiotic-resistant bacteria, which costs society 1.5 billion euro (US$2.2 billion) a year.

Today's report said only 15 new anti-bacterial drugs are under development, most of which are in very early stages.

MRSA, or methicillin-resistant Staphylococcus aureus, is the most common superbug, but others are increasing steadily.

World

About Us
|
Terms of Use
|
RSS
|
Privacy Policy
|
Contact Us
|
Shanghai Call Center: 962288
|
Tip-off hotline: 52920043

沪ICP证：沪ICP备05050403号-1
|
互联网新闻信息服务许可证：31120180004
|
网络视听许可证：0909346
|
广播电视节目制作许可证：沪字第354号
|
增值电信业务经营许可证：沪B2-20120012

New drugs needed to tackle superbugs

Email this to your friend